Fig. 10.
In vitro cytotoxicity of MNCs from G-CSF–mobilized and nonmobilized steady-state apheresis product.
In vitro cytotoxicity of MNCs from G-CSF–mobilized (n = 77) and nonmobilized steady-state apheresis product (n = 20) against K562 (panel A) and Raji (panel B) tumor target cells as expressed per absolute number of MNCs. ● indicates G-CSF mobilized donors; ○, nonmobilized donors.